We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
Turnover
69.33%
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.43B
AUM Growth
-$4.45B
(-76%)
Cap. Flow
-$4.6B
Cap. Flow
% of AUM
-322.21%
Top 10 Holdings %
Top 10 Hldgs %
25.3%
Holding
613
New
146
Increased
30
Reduced
152
Closed
279
Avg Time Held Equity + Options
0.6
years
Top 10 Avg Time Held Equity + Options
0
years
Top 20 Avg Time Held Equity + Options
0
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
0
years
Top 20 Avg Time Held Equity only
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$24.8M |
| 2 |
KBR
KBR
|
+$24.5M |
| 3 |
MRD
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
|
+$11.4M |
| 4 |
Scorpio Tankers
STNG
|
+$9.89M |
| 5 |
MGIC Investment
MTG
|
+$9.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$280M |
| 2 |
AGN
Allergan plc
AGN
|
+$227M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$138M |
| 4 |
Pacira BioSciences
PCRX
|
+$119M |
| 5 |
Centene
CNC
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.43% |
| 2 | Technology | 11.54% |
| 3 | Financials | 10.92% |
| 4 | Energy | 8.32% |
| 5 | Industrials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Protolabs
PRLB
$2.04B
| $423K | 0.03% |
+7,349
| New | +$491K |
2016 Q2
0 quarters
|
|
|
GCP
277
DELISTED
GCP Applied Technologies Inc.
GCP
| $413K | 0.03% |
15,837
+223
| +1% | +$5.23K |
2016 Q1
1 quarter
|
|
278
DELISTED
Du Pont De Nemours E I
DD
| $411K | 0.03% |
6,337
-507,138
| -99% | -$33.3M |
2016 Q1
1 quarter
|
|
|
TCON
279
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $405K | 0.03% |
462
-1,538
| -77% | -$2.04M |
2015 Q1
5 quarters
|
|
|
MON
280
DELISTED
Monsanto Co
MON
| $393K | 0.03% |
+3,797
| New | +$376K |
2016 Q2
0 quarters
|
|
|
NYRT
281
DELISTED
New York REIT, Inc.
NYRT
| $367K | 0.03% |
+3,960
| New | +$383K |
2016 Q2
0 quarters
|
|
|
TA
282
DELISTED
TravelCenters of America LLC
TA
| $355K | 0.02% |
+8,697
| New | +$317K |
2016 Q2
0 quarters
|
|
283
Franklin Electric
FELE
$4.46B
| $354K | 0.02% |
+10,706
| New | +$349K |
2016 Q2
0 quarters
|
|
|
HDS
284
DELISTED
HD Supply Holdings, Inc.
HDS
| $354K | 0.02% |
10,172
-108,470
| -91% | -$3.69M |
2015 Q3
3 quarters
|
|
285
Avis
CAR
$3.84B
| $346K | 0.02% |
+10,749
| New | +$297K |
2016 Q2
0 quarters
|
|
286
Enovis
ENOV
$1.11B
| $330K | 0.02% |
+7,265
| New | +$355K |
2016 Q2
0 quarters
|
|
|
ALR
287
CALL
DELISTED
Alere Inc
ALR
| $330K | 0.02% |
7,900
-2,100
| -21% | -$91.1K |
2016 Q1
1 quarter
|
|
|
IPHI
288
DELISTED
INPHI CORPORATION
IPHI
| $328K | 0.02% |
10,221
-226,788
| -96% | -$7.11M |
2016 Q1
1 quarter
|
|
|
STKL
289
DELISTED
SunOpta
STKL
| $326K | 0.02% |
+77,892
| New | +$360K |
2016 Q2
0 quarters
|
|
290
DELISTED
Chart Industries
GTLS
| $318K | 0.02% |
+13,180
| New | +$325K |
2016 Q2
0 quarters
|
|
291
PUT
Alibaba
BABA
$274B
| $311K | 0.02% |
+3,900
| New | +$305K |
2016 Q2
0 quarters
|
|
|
GNMK
292
DELISTED
GenMark Diagnostics, Inc
GNMK
| $307K | 0.02% |
35,235
-264,765
| -88% | -$1.82M |
2013 Q3
11 quarters
|
|
|
RAD
293
PUT
DELISTED
Rite Aid Corporation
RAD
| $297K | 0.02% |
+1,980
| New | +$312K |
2016 Q2
0 quarters
|
|
294
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $290K | 0.02% |
+4,381
| New | +$300K |
2016 Q2
0 quarters
|
|
295
Pacific Biosciences
PACB
$597M
| $279K | 0.02% |
+39,659
| New | +$362K |
2016 Q2
0 quarters
|
|
296
Constellium
CSTM
$3.44B
| $278K | 0.02% |
59,291
-324,073
| -85% | -$1.66M |
2015 Q1
5 quarters
|
|
297
Ashland
ASH
$3.25B
| $266K | 0.02% |
4,732
-129,066
| -96% | -$7.14M |
2013 Q2
12 quarters
|
|
298
Magnachip Semiconductor
MX
$198M
| $257K | 0.02% |
45,298
-56,678
| -56% | -$302K |
2013 Q2
12 quarters
|
|
299
Himax Technologies
HIMX
$2.08B
| $250K | 0.02% |
+30,345
| New | +$299K |
2016 Q2
0 quarters
|
|
300
Pfizer
PFE
$170B
| $247K | 0.02% |
7,378
-2,254,940
| -100% | -$72M |
2014 Q3
7 quarters
|
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Visium Asset Management held 613 positions worth $1.43B, down 76% from $5.88B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Visium Asset Management withdrew a net $4.6B in Q2 2016, closing 279 positions and reducing 152 holdings. Its most notable exit was Labcorp, an estimated $280M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 7.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Visium Asset Management opened a new position in Marathon Petroleum worth $25.6M.
- Visium Asset Management's largest Q2 2016 buy was Marathon Petroleum: 674,173 shares worth $25.6M.
- Visium Asset Management added most to Nasdaq in Q2 2016, an estimated $7.06M increase.
- Visium Asset Management's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $227M.
- Visium Asset Management fully exited Labcorp in Q2 2016, selling an estimated $280M.
- Visium Asset Management's ten largest holdings make up 25% of its $1.43B portfolio in Q2 2016.
- Visium Asset Management opened 146 new positions and closed 279 in Q2 2016.
- Visium Asset Management's portfolio value fell 76% quarter-over-quarter to $1.43B.
Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.